Specific features of hormonal contraception


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Objective. To investigate the efficacy of the contraceptive agent bonade. Subjects and methods. Forty 18-to-35-year old women using bonade for contraception were examined. Their follow-up lasted 3 months. Complaints and objective examination, genital ultrasound, and laboratory findings were analysed to evaluate the efficiency of the drug. Results. The patients tolerated bonade well. The incidence of the drug’s adverse reactions was comparable with that of the agents of the same group. Conclusion. Assessing the results obtained during the investigation shows that bonade may be recommended for use as a contraceptive agent. The drug is well tolerated and causes a few adverse reactions that go away within the first months of its administration.

全文:

受限制的访问

作者简介

Tatyana Provotorova

Institute of Advanced Postgraduate Education, N.N. Burdenko Voronezh State Medical University

Email: kololoka@yandex.ru
Postgraduate student, Department Obstetrics and Gynecology

Nicolay Minaev

Institute of Advanced Postgraduate Education, N.N. Burdenko Voronezh State Medical University

Email: mnn@vmail.ru
MD, professor of department obstetrics and gynecology

参考

  1. Прилепская В.Н. Гормональная контрацепция. Клинические лекции. М.: ГЭОТАР-Медиа; 2014: 12-7. [Prilepskaya V.N. Hormonal contraception. Clinical lectures. Moscow: GEOTAR Media; 2014: 12-7. (in Russian)]
  2. Lethaby A., Irvine G.A., Cameron I.T. Cyclical progestogens for heavy menstrual bleeding. Cochrane Database Syst. Rev. 2008; (1): CD001016.
  3. Подзолкова Н.М., Роговская С.И., Колода Ю.А. Современная контрацепция. Новые возможности и критерии безопасности. Руководство для врачей. М.: ГЭОТАР-Медиа; 2013: 1-5. [Podzolkova N.M., Rogovskaya S.I., Koloda Yu.A. Modern contraception. New features and safety criteria. Guide for physicians. Moscow: GEOTAR Media; 2013: 1-5. (in Russian)]
  4. Тихомиров А.Л. 35 лет ежемесячных кровопотерь и спазмов у женщин -триггер патологии. Русский медицинский журнал. 2009; 17(1): 1-3. [Tikhomirov A.L. 35 years of monthly blood loss and cramps in women -trigger disease. Russian Medical Journal. 2009; 17 (1): 1-3. (in Russian)]
  5. Oettel M., Bervoas-Martin S., Elger W., Golbs S., Hobe G., Kaufmann G. et al. A 19-nonprogestin without 17a-ethinyl group II: dienogest from a pharmacokinetic point of view. Drugs Today. 1995; 31(7): 499-516.
  6. National Collaborating Centre for Women’s and Children’s Health. Heavy Menstrual Bleeding. NICE Clinical Guidelines no. 44. London: RCOG Press; 2007: January. Available at: http//www.nice.org.uk/nicemedia/pdf/ CG44FullGuideline.pdf.
  7. Stewart A., Cummins C., Gold L., Jordan R., Phillips W. The effectiveness of the levonorgestrel-releasing intrauterine system in menorrahagia: a systematic review. BJOG: Br. J. Obstet. Gynaecol. 2001; 108(1): 74-86.
  8. Сметник В.П., Тумилович Л.Г. Неоперативная гинекология. Руководство для врачей. СПб.: СОТИС; 1995. 224с. [Smetnik V.P., Tumilovich L.G. Non-immediate gynecology. Guide for physicians. Saint Petersburg: SOTIS; 1995. 224p. (in Russian)]

补充文件

附件文件
动作
1. JATS XML

版权所有 © Bionika Media, 2015
##common.cookie##